Form 990 for tax year 2025
Filed by FOUNDATION FOR SARCOIDOSIS RESEARCH.
Totals
- Total revenue
- $4,662,058
- Total expenses
- $3,810,958
- Contributions and grants received
- $3,985,033
- Grants paid
- $875,600
- Program service revenue
- $97,267
- Investment income
- $717,533
- Other revenue
- -$137,775
- Total assets, end of year
- $18,793,381
- Total liabilities, end of year
- $1,107,498
- Net assets or fund balances, end of year
- $17,685,883
- Program services expenses (Part IX)
- $2,865,533
- Management and general expenses
- $681,883
- Fundraising expenses
- $263,542
- Program service expenses (Part III)
- $2,865,533
Program services were 75.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1b · Membership dues
$172,341
-
1c · Fundraising events
$148,000
-
1f · All other contributions, gifts and grants
$3,664,692
-
1g · Noncash contributions included above
$3,489
-
2a · Program service revenue: PROGRAM SERVICE FEES
total $85,903 · related or exempt $85,903
-
2b · Program service revenue: PATIENT EVENTS
total $11,364 · related or exempt $11,364
-
3 · Investment income
total $518,767 · excluded $518,767
-
7a · Gross sales of assets other than inventory
securities $5,046,765
-
7b · Less cost or other basis and sales expenses
securities $4,847,999
-
7c · Gain or loss
securities $198,766
-
7d · Net gain or loss
total $198,766 · excluded $198,766
-
8a · Fundraising events: gross income
$5,000
-
8a · Fundraising events: contributions included on line 1c
$148,000
-
8b · Fundraising events: direct expenses
$154,900
-
8c · Net income from fundraising events
total -$149,900 · excluded -$149,900
-
11a · Other revenue: MISCELLANEOUS INCOME
total $12,125 · excluded $12,125
-
11e · Other revenue, total
$12,125
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $476,000 · program services $476,000
-
3 · Grants to foreign organizations and individuals
total $399,600 · program services $399,600
-
5 · Compensation of officers, directors and key employees
total $597,807 · program services $425,788 · management and general $103,624 · fundraising $68,395
-
7 · Other salaries and wages
total $956,777 · program services $681,464 · management and general $165,848 · fundraising $109,465
-
8 · Pension plan contributions
total $25,096 · program services $17,875 · management and general $4,350 · fundraising $2,871
-
9 · Other employee benefits
total $74,212 · program services $52,857 · management and general $12,864 · fundraising $8,491
-
10 · Payroll taxes
total $118,489 · program services $84,394 · management and general $20,539 · fundraising $13,556
-
11b · Fees: legal
total $5,248 · program services $56 · management and general $5,192
-
11c · Fees: accounting
total $102,954 · program services $1,097 · management and general $101,857
-
11f · Fees: investment management
total $46,942 · management and general $46,942
-
11g · Fees: other
total $299,818 · program services $237,454 · management and general $56,953 · fundraising $5,411
-
12 · Advertising and promotion
total $16,868 · program services $16,059 · fundraising $809
-
13 · Office expenses
total $107,810 · program services $57,631 · management and general $32,562 · fundraising $17,617
-
14 · Information technology
total $146,635 · program services $66,656 · management and general $60,170 · fundraising $19,809
-
16 · Occupancy
total $30,696 · management and general $30,696
-
17 · Travel
total $85,103 · program services $69,083 · management and general $14,316 · fundraising $1,704
-
19 · Conferences, conventions and meetings
total $65,715 · program services $63,363 · management and general $1,085 · fundraising $1,267
-
23 · Insurance
total $7,128 · program services $1,188 · management and general $5,862 · fundraising $78
-
24a · Other expenses: RESEARCH PROGRAMS
total $139,691 · program services $127,284 · management and general $6,929 · fundraising $5,478
-
24b · Other expenses: HONORARIUMS
total $61,506 · program services $61,506
-
24c · Other expenses: DUES AND SUBSCRIPTIONS
total $30,136 · program services $14,451 · management and general $7,094 · fundraising $8,591
-
24d · Other expenses: CONTRACTS
total $11,727 · program services $11,727
-
24e · All other expenses
total $5,000 · management and general $5,000
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $759,559 · end of year $4,722,970
-
3 · Pledges and grants receivable
beginning of year $187,301 · end of year $347,834
-
4 · Accounts receivable
beginning of year $98,186 · end of year $24,419
-
9 · Prepaid expenses and deferred charges
beginning of year $66,514 · end of year $39,450
-
10a · Land, buildings and equipment: cost or other basis
$0
-
10b · Land, buildings and equipment: accumulated depreciation
$0
-
10c · Land, buildings and equipment, net
beginning of year $0 · end of year $0
-
11 · Investments: publicly traded securities
beginning of year $16,071,598 · end of year $13,658,708
-
17 · Accounts payable and accrued expenses
beginning of year $321,294 · end of year $29,187
-
18 · Grants payable
beginning of year $845,304 · end of year $1,077,341
-
19 · Deferred revenue
beginning of year $5,833 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $970
-
27 · Net assets without donor restrictions
beginning of year $14,502,618 · end of year $16,582,058
-
28 · Net assets with donor restrictions
beginning of year $1,508,109 · end of year $1,103,825
Mission and programs · 2025
Mission
THE FOUNDATION FOR SARCOIDOSIS RESEARCH (FSR) IS THE LEADING INTERNATIONAL ORGANIZATION DEDICATED TO FINDING A CURE FOR SARCOIDOSIS AND IMPROVING CARE FOR SARCOIDOSIS PATIENTS THROUGH RESEARCH, EDUCATION, AND SUPPORT. SINCE ITS ESTABLISHMENT IN 2000, FSR HAS FOSTERED OVER $7.5 MILLION IN SARCOIDOSIS SPECIFIC RESEARCH EFFORTS.
-
FSR RESEARCH FUNDING - THE FOUNDATION FOR SARCOIDOSIS RESEARCH PROVIDED $875,600 IN SARCOIDOSIS RESEARCH FUNDING IN 2025. FSR PROVIDED THREE FELLOWSHIPS IN THE AMOUNT OF $150,000 EACH, TWO CARDIAC GRANTS IN THE AMOUNT OF $100,000 EACH, TWO PILOT GRANTS IN THE AMOUNTS OF $100,000 AND $99,600, AND ONE FSR/AMERICAN HEART ASSOCIATION PARTNER GRANT IN THE AMOUNT OF $26,000. FSR ALSO HOSTS A PATIENT REGISTRY WITH NEARLY 7,500 PARTICIPANTS FROM 68 COUNTRIES AND PROVIDES ONGOING SUPPORT TO ACADEMIA AND INDUSTRY IN ENSURING ALL CLINICAL TRIALS AND RESEARCH ARE PATIENT CENTERED.
Expenses $1,553,084 · Grants $844,600 · Revenue $85,903
-
FSR GLOBAL SARCOIDOSIS CLINIC ALLIANCE (FSR-GSCA) CLINICAL SUPPORT - COMPRISED OF 46 MEMBER INSTITUTIONS, THE FSR-GSCA IS A POWERFUL NETWORK OF INSTITUTIONS THAT SUPPORT PATIENTS, CAREGIVERS, AND CLINICIANS, THROUGH EDUCATIONAL AND SUPPORT PROGRAMMING. THE FSR-GSCA REACHES OVER 4000 CLINICIANS WITH CLINICAL EDUCATION PROGRAMMING FROM OVER 40 COUNTRIES. THROUGH THIS PROGRAM, FSR COORDINATES CONTINUING EDUCATION EDUCATIONAL PROGRAMS FOR CLINICIANS INCLUDING THE FSR CLINICAL EDUCATION AND ENGAGEMENT SERIES, THE FSR JOURNAL CLUB, AND THE FSR CASE CONFERENCE PROGRAM, WHICH PROVIDE INSIGHTS THAT LEAD TO PRACTICE CHANGING BEHAVIOR BY ATTENDEES AND PARTICIPANTS. FSR IS NOW SUPPORTING REGIONAL CLINICAL EDUCATION MEETINGS THROUGH PROGRAM AND MARKETING SUPPORT TO REACH BEYOND EXPERTS TO THE POOL OF LOCAL PHYSICIANS AND ADVANCED PRACTITIONERS.
Expenses $1,096,474 · Grants $31,000 · Revenue $11,364
-
FSR PATIENT SUPPORT AND EDUCATION - FSR PROVIDES EXTENSIVE SUPPORT TO PATIENT AND CAREGIVERS IMPACTED BY SARCOIDOSIS THROUGH INFORMATION & REFERRAL SERVICES, ASSISTANCE TO FINANCIAL RESOURCES, 1:1 PEER TO PEER PATIENT SUPPORT PROGRAM (PATIENT NAVIGATORS), NATIONAL VIRTUAL SUPPORT GROUP, AND LOCAL SUPPORT GROUPS AFFILIATED WITH THE FSR GLOBAL SARCOIDOSIS CLINIC ALLIANCE. FSR HOSTS WEBINARS, TOWN HALLS, PODCASTS, VIRTUAL SUMMITS, AND IN-PERSON EDUCATIONAL EVENTS TO PROVIDE PATIENTS AND FAMILY MEMBERS WITH EDUCATION FROM WORLD-RENOWNED SARCOIDOSIS EXPERTS. FSR WORKS WITH THE NIH, FDA, AND DOD TO ENSURE THE SARCOIDOSIS IS CONSIDERED IN ALL ASPECTS FOR FEDERAL RESEARCH AND DRUG DEVELOPMENT. FSR IS COMMITTED TO ENSURING CLINICAL TRIALS REPRESENT ALL IN OUR COMMUNITY AND HAS BEEN LEADING EFFORTS TO REDUCE BARRIERS TO CLINICAL TRIAL ACCESS, INCLUDING COVERAGE UNDER FMLA AND PAID TIME OFF.
Expenses $215,975
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Mary CobbMARY COBB
PRESIDENT
- Total calculated
- $0
- Hours/week
- 10
-
Calvin HarrisCALVIN HARRIS
TREASURER
- Total calculated
- $0
- Hours/week
- 5
-
Joel RosenJOEL ROSEN
SECRETARY
- Total calculated
- $0
- Hours/week
- 5
-
John CarlinJOHN CARLIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Yvette C CozierYVETTE C COZIER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Molly FlickMOLLY FLICK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Emerson Randy Hall JrEMERSON RANDY HALL JR
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Michael KlingherMICHAEL KLINGHER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Joan LevyJOAN LEVY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Craig LipsetCRAIG LIPSET
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
John MockovciakJOHN MOCKOVCIAK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Louise M PerkinsLOUISE M PERKINS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jeffrey RaichJEFFREY RAICH
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Leslie SerchuckLESLIE SERCHUCK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mary McGowanMARY MCGOWAN
PRESIDENT & CEO
- Total calculated
- $325,094
- From this org
- $297,500
- From related orgs
- $0
- Other
- $27,594
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $282,500
- Bonus
- $15,000
- Other
- $0
- Deferred
- $13,125
- Nontaxable benefits
- $14,469
- Filer's total
- $325,094
-
Tricha ShivasTRICHA SHIVAS
CHIEF OF STAFF AND STRATEGY
- Total calculated
- $272,713
- From this org
- $248,750
- From related orgs
- $0
- Other
- $23,963
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $218,750
- Bonus
- $30,000
- Other
- $0
- Deferred
- $10,350
- Nontaxable benefits
- $13,613
- Filer's total
- $272,713
-
David FischerDAVID FISCHER
DIRECTOR OF OPERATIONS
- Total calculated
- $107,801
- From this org
- $103,220
- From related orgs
- $0
- Other
- $4,581
- Hours/week
- 40
-
Elise HooverELISE HOOVER
VP OF RESEARCH
- Total calculated
- $162,698
- From this org
- $150,067
- From related orgs
- $0
- Other
- $12,631
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $147,067
- Bonus
- $3,000
- Other
- $0
- Deferred
- $6,430
- Nontaxable benefits
- $6,201
- Filer's total
- $162,698
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$150,000
RESEARCH FELLOWSHIP
-
$100,000
CARDIAC RESEARCH GRANT
-
$100,000
RESEARCH GRANT
-
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
$100,000
CARDIAC RESEARCH GRANT
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 31 August 2026
- IRS schema version
- 2025v4.2
- Source object
- 202642479349300444
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.